Just to add to the above post, I had a quick look at what Napp Pharmaceuticals do, because Pharmas don’t usually do these studies unless it relates to their products.
What a surprise, looks like they are the UK distributor of Janssen’s Invokana:
https://napp.co.uk
one of the external link diabetes websites they maintain. Happy to see that the CVD & CKD outcomes are listed there on their UK website:
https://www.invokana.co.uk/why-chose-invokana/cardiovascular-renal-outcomes/
Interesting.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $48.23M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 29.0¢ | $142.3K | 476.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5758 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 10000 | 3 |
View Market Depth
| Last trade - 13.32pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |